CXCL6 and cholangiocarcinoma: Eventually, CXCL6 could reshape lipid metabolism in CCA cells, and its overexpression also related to CCA immunotherapy resistance since CXCL6 induced NETs formation and led to reduced infiltration of CD8+ T cells.